Cargando…
Can kidney parenchyma metabolites serve as prognostic biomarkers for long-term kidney function after nephrectomy for renal cell carcinoma? A preliminary study
OBJECTIVE: Nephrectomy, the standard of care for localized renal cell carcinoma (RCC), may lead to kidney function loss. Our goal was to identify prognostic biomarkers of postoperative renal function using metabolomics. METHODS: Metabolomics data from benign kidney parenchyma were collected prospect...
Autores principales: | Rosenzweig, Barak, Recabal, Pedro, Gluck, Caroline, Coleman, Jonathan A, Susztak, Katalin, Hakimi, A Ari, Jaimes, Edgar A, Weiss, Robert H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894921/ https://www.ncbi.nlm.nih.gov/pubmed/35261758 http://dx.doi.org/10.1093/ckj/sfaa185 |
Ejemplares similares
-
Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patients
por: Rosenzweig, Barak, et al.
Publicado: (2017) -
Preoperative Renal Parenchyma Volume as a Predictor of Kidney Function Following Nephrectomy of Complex Renal Masses
por: Antony, Maria B., et al.
Publicado: (2023) -
Fat Burning Problem in Cystic Kidneys: an Emerging Common Mechanism of Chronic Kidney Disease
por: Li, Szu Yuan, et al.
Publicado: (2016) -
Getting a Notch Closer to Understanding Diabetic Kidney Disease
por: Ahn, Seon-Ho, et al.
Publicado: (2010) -
Kick it up a notch: Notch signaling and kidney fibrosis
por: Sweetwyne, Mariya T, et al.
Publicado: (2014)